Bank of America’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,040
| Closed | -$12.5K | – | 6256 |
|
|
2025
Q4 | $12.5K | Hold |
2,040
| – | – | ﹤0.01% | 6120 |
|
|
2025
Q3 | $12.8K | Sell |
2,040
-55
| -3% | -$348 | ﹤0.01% | 7156 |
|
|
2025
Q2 | $14.6K | Buy |
2,095
+8
| +0.4% | +$47 | ﹤0.01% | 7116 |
|
|
2025
Q1 | $10K | Buy |
2,087
+2
| +0.1% | +$10 | ﹤0.01% | 7112 |
|
|
2024
Q4 | $10.7K | Buy |
2,085
+7
| +0.3% | +$28 | ﹤0.01% | 6966 |
|
|
2024
Q3 | $7.54K | Buy |
2,078
+1
| +0% | +$4 | ﹤0.01% | 6942 |
|
|
2024
Q2 | $10.1K | Buy |
2,077
+45
| +2% | +$217 | ﹤0.01% | 6894 |
|
|
2024
Q1 | $10.8K | Sell |
2,032
-3
| -0.1% | -$15 | ﹤0.01% | 6874 |
|
|
2023
Q4 | $10.4K | Buy |
2,035
+3
| +0.1% | +$15 | ﹤0.01% | 6902 |
|
|
2023
Q3 | $10.8K | Hold |
2,032
| – | – | ﹤0.01% | 6842 |
|
|
2023
Q2 | $10.2K | Hold |
2,032
| – | – | ﹤0.01% | 6859 |
|
|
2023
Q1 | $10.4K | Sell |
2,032
-6
| -0.3% | -$39 | ﹤0.01% | 6908 |
|
|
2022
Q4 | $12.4K | Buy |
2,038
+6
| +0.3% | +$43 | ﹤0.01% | 6869 |
|
|
2022
Q3 | $15K | Hold |
2,032
| – | – | ﹤0.01% | 7124 |
|
|
2022
Q2 | $17K | Hold |
2,032
| – | – | ﹤0.01% | 7227 |
|
|
2022
Q1 | $20K | Sell |
2,032
-10
| -0.5% | -$86 | ﹤0.01% | 7514 |
|
|
2021
Q4 | $16K | Sell |
2,042
-19
| -0.9% | -$170 | ﹤0.01% | 7581 |
|
|
2021
Q3 | $19K | Buy |
2,061
+29
| +1% | +$274 | ﹤0.01% | 7402 |
|
|
2021
Q2 | $20K | Sell |
2,032
-22
| -1% | -$215 | ﹤0.01% | 7129 |
|
|
2021
Q1 | $20K | Buy |
2,054
+22
| +1% | +$206 | ﹤0.01% | 6884 |
|
|
2020
Q4 | $12K | Sell |
2,032
-32
| -2% | -$186 | ﹤0.01% | 6685 |
|
|
2020
Q3 | $11K | Sell |
2,064
-5
| -0.2% | -$28 | ﹤0.01% | 6429 |
|
|
2020
Q2 | $9K | Buy |
2,069
+37
| +2% | +$161 | ﹤0.01% | 6466 |
|
|
2020
Q1 | $8K | Sell |
2,032
-980
| -33% | -$4.82K | ﹤0.01% | 6414 |
|
|
2019
Q4 | $16K | Sell |
3,012
-42
| -1% | -$217 | ﹤0.01% | 6544 |
|
|
2019
Q3 | $17K | Sell |
3,054
-27
| -0.9% | -$158 | ﹤0.01% | 6615 |
|
|
2019
Q2 | $20K | Buy |
3,081
+69
| +2% | +$438 | ﹤0.01% | 6565 |
|
|
2019
Q1 | $19K | Sell |
3,012
-4
| -0.1% | -$29 | ﹤0.01% | 6507 |
|
|
2018
Q4 | $21K | Sell |
3,016
-127
| -4% | -$982 | ﹤0.01% | 6477 |
|
|
2018
Q3 | $26K | Buy |
3,143
+1,108
| +54% | +$7.97K | ﹤0.01% | 6425 |
|
|
2018
Q2 | $13K | Buy |
2,035
+3
| +0.1% | +$22 | ﹤0.01% | 6601 |
|
|
2018
Q1 | $15K | Hold |
2,032
| – | – | ﹤0.01% | 6477 |
|
|
2017
Q4 | $17K | Sell |
2,032
-15
| -0.7% | -$123 | ﹤0.01% | 6463 |
|
|
2017
Q3 | $13K | Buy |
2,047
+15
| +0.7% | +$98 | ﹤0.01% | 6444 |
|
|
2017
Q2 | $15K | Hold |
2,032
| – | – | ﹤0.01% | 6305 |
|
|
2017
Q1 | $11K | Hold |
2,032
| – | – | ﹤0.01% | 6516 |
|
|
2016
Q4 | $12K | Sell |
2,032
-213
| -9% | -$1.3K | ﹤0.01% | 6497 |
|
|
2016
Q3 | $18K | Buy |
2,245
+213
| +10% | +$1.55K | ﹤0.01% | 6170 |
|
|
2016
Q2 | $14K | Hold |
2,032
| – | – | ﹤0.01% | 6386 |
|
|
2016
Q1 | $13K | Hold |
2,032
| – | – | ﹤0.01% | 6296 |
|
|
2015
Q4 | $16K | Hold |
2,032
| – | – | ﹤0.01% | 6509 |
|
|
2015
Q3 | $12K | Hold |
2,032
| – | – | ﹤0.01% | 6500 |
|
|
2015
Q2 | $16K | Hold |
2,032
| – | – | ﹤0.01% | 6422 |
|
|
2015
Q1 | $13K | Hold |
2,032
| – | – | ﹤0.01% | 6214 |
|
|
2014
Q4 | $9K | Hold |
2,032
| – | – | ﹤0.01% | 7102 |
|
|
2014
Q3 | $10K | Sell |
2,032
-42
| -2% | -$196 | ﹤0.01% | 7318 |
|
|
2014
Q2 | $9K | Buy |
2,074
+42
| +2% | +$177 | ﹤0.01% | 7500 |
|
|
2014
Q1 | $9K | Sell |
2,032
-4
| -0.2% | -$17 | ﹤0.01% | 7211 |
|
|
2013
Q4 | $9K | Buy |
2,036
+4
| +0.2% | +$17 | ﹤0.01% | 7318 |
|
|
2013
Q3 | $9K | Hold |
2,032
| – | – | ﹤0.01% | 7199 |
|
|
2013
Q2 | $8K | Buy |
+2,032
| New | +$7.28K | ﹤0.01% | 7227 |
|
Other funds holding ICCC
VCM
CAM
BL
S
VFT
MFIM
Bank of America's ICCC Position: Q1 2026 in Review
Bank of America sold out of ImmuCell (ICCC) in Q1 2026, closing a stake of 2,040 shares — an estimated $12.5K sold.
Bank of America first reported a position in ICCC in Q2 2013 and held it in 51 quarters. The position peaked at $26K in Q3 2018. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.
- Bank of America reported no remaining ImmuCell position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 2,040 ImmuCell shares in Q1 2026, an estimated $12.5K.
- Bank of America first reported a position in ImmuCell in Q2 2013 and held it in 51 quarters.
- Bank of America's ImmuCell position peaked at $26K in Q3 2018.
- 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.